Modulation of the Course and Outcome of Blood-Stage Malaria by Erythropoietin-Induced Reticulocytosis

Journal of Infectious Diseases

Volumn 189, Issue 4, 2004, Pages 735-743

  Chang, Kai Hsin ^a,b   Tam, Mifong ^b   Stevenson, Mary M ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; POLYCLONAL ANTIBODY;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ERYTHROPOIESIS; HOST SUSCEPTIBILITY; INFECTION; MALARIA; MORTALITY; MOUSE; NONHUMAN; OUTCOMES RESEARCH; PLASMODIUM CHABAUDI; PRIORITY JOURNAL; PROTEIN FUNCTION; RETICULOCYTOSIS; SURVIVAL RATE;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; EPOETIN ALFA; MALARIA; MALE; MICE; MICE, INBRED A; MICE, INBRED C57BL; PLASMODIUM CHABAUDI; RETICULOCYTOSIS; TREATMENT OUTCOME;

EID: 1442349713     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/381458     Document Type: Article

References (32)

1. Obonyo CO, Steyerberg EW, Oloo AJ, Habbema JD. Blood transfusions for severe malaria-related anemia in Africa: a decision analysis. Am J Trop Med Hyg 1998; 59:808-12.
2. Moore SA, Surgey EG, Cadwgan AM. Malaria vaccines: where are we and where are we going? Lancet Infect Dis 2002; 2:737-43.
3. Egan AF, Blackman MJ, Kaslow DC. Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys. Infect Immun 2000; 68:1418-27.
4. Jones TR, Narum DL, Gozalo AS, et al. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen. J Infect Dis 2001; 183:303-12.
5. Weatherall DJ, Abdalla S, Pippard MJ. The anaemia of Plasmodium falciparum malaria. Ciba Found Symp 1983; 94:74-97.
6. Villeval JL, Lew A, Metcalf D. Changes in hemopoietic and regulator levels in mice during fatal or nonfatal malarial infections. I. Erythropoietic populations. Exp Parasitol 1990; 71:364-74.
7. Kurtzhals JA, Rodrigues O, Addae M, Commey JO, Nkrumah FK, Hviid L. Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria. Br J Haematol 1997; 97:169-74.
8. Yap GS, Stevenson MM. Plasmodium chabaudi AS: erythropoietic responses during infection in resistant and susceptible mice. Exp Parasitol 1992; 75:340-52.
9. Burchard GD, Radloff P, Philipps J, Nkeyi M, Knobloch J, Kremsner PG. Increased erythropoietin production in children with severe malarial anemia. Am J Trop Med Hyg 1995; 53:547-51.
10. Burgmann H, Looareesuwan S, Kapiotis S, et al. Serum levels of erythropoietin in acute Plasmodium falciparum malaria. Am J Trop Med Hyg 1996; 54:280-3.
11. el Hassan AM, Saeed AM, Fandrey J, Jelkmann W. Decreased erythropoietin response in Plasmodium falciparum malaria-associated anaemia. Eur J Haematol 1997; 59:299-304.
12. Nussenblatt V, Mukasa G, Metzger A, Ndeezi G, Garrett E, Semba RD. Anemia and interleukin-10, tumor necrosis factor alpha, and erythropoietin levels among children with acute, uncomplicated Plasmodium falciparum malaria. Clin Diagn Lab Immunol 2001; 8:1164-70.
13. Chang K-H, Stevenson MM. Effect of anemia and renal cytokine production on erythropoietin production during blood-stage malaria. Kidney Int (in press).
14. Dormer P, Dietrich M, Kern P, Horstmann, RD. Ineffective erythropoiesis in acute human P. falciparum malaria. Blut 1983; 46:279-88.
15. Clark IA, Chaudhri G. Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis. Br J Haematol 1988; 70:99-103.
16. Wickramasinghe SN, Looareesuwan S, Nagachinta B, White NJ. Dyserythropoiesis and ineffective erythropoiesis in Plasmodium vivax malaria. Br J Haematol 1989; 72:91-9.
17. Stevenson MM, Lyanga JJ. Skamene E. Murine malaria: genetic control of resistance to Plasmodium chabaudi. Infect Immun 1982; 38:80-8.
18. Chang K-H, Stevenson MM. Comparison of murine Epo ELISA and Epo bioassays in detecting serum Epo levels during anemia associated with malaria infection. J Immunol Methods 2002; 262:129-36.
19. Sam H, Stevenson MM. In vivo IL-12 production and IL-12 receptors β1 and β2 mRNA expression in the spleen are differentially up-regulated in resistant B6 and susceptible A/J mice during early blood-stage Plasmodium chabaudi AS malaria. J Immunol 1999; 162:1582-9.
20. Fisher JW. Erythropoietin: physiology and pharmacology update. Exp Biol Med (Maywood) 2003; 228:1-14.
21. Marsh WA, Rascati KL. Meta-analyses of the effectiveness of erythropoietin for end-stage renal disease and cancer. Clin Ther 1999; 21: 1443-55.
22. Hetzel C, Anderson RM. The within-host cellular dynamics of bloodstage malaria: theoretical and experimental studies. Parasitology 1996; 113:25-38.
23. Yap GS, Jacobs P, Stevenson MM. Th cell regulation of host resistance to blood-stage Plasmodium chabaudi AS. Res Immunol 1994; 145:419-22.
24. Stevenson MM, Su Z, Sam H, Mohan K. Modulation of host responses to blood-stage malaria by interleukin-12: from therapy to adjuvant activity. Microbes Infect 2001; 3:49-59.
25. Yap GS, Stevenson MM. Blood transfusion alters the course and outcome of Plasmodium chabaudi AS infection in mice. Infect Immun 1994; 62:3761-5.
26. Mittelman M, Neumann D, Peled A, Kanter P, Haran-Ghera N. Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models. Proc Natl Acad Sci USA 2001; 98:5181-6.
27. Stevenson MM, Tam MF. Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible mice. Clin Exp Immunol 1993; 92:77-83.
28. Jacobs P, Radzioch D, Stevenson MM. A Th1-associated increase in tumor necrosis factor alpha expression in the spleen correlates with resistance to blood-stage malaria in mice. Infect Immun 1996; 64:535-41.
29. Blau CA, Constantoulakis P, al-Khatti A, et al. Fetal hemoglobin in acute and chronic states of erythroid expansion. Blood 1993; 81:227-33.
30. Shear HL, Grinberg L, Gilman J, et al. Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism. Blood 1998; 92:2520-6.
31. Pappas S, Cauchi MN. Factors affecting haemoglobin synthesis in the mouse. Exp Hematol 1982; 10:761-7.
32. Mitchell GH, Hadley TJ, McGinniss MH, Klotz FW, Miller LH. Invasion of erythrocytes by Plasmodium falciparum malaria parasites: evidence for receptor heterogeneity and two receptors. Blood 1986; 67:1519-21.